| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/07/2001 | EP1150674A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation |
| 11/07/2001 | EP1150673A1 Mono-acyloxy aralkyl neuromuscular relaxants |
| 11/07/2001 | EP1150672A1 Method to aid smoking cessation |
| 11/07/2001 | EP1150671A1 Use of pyrethroid compounds to promote hair growth |
| 11/07/2001 | EP1150670A2 Alkylating agents for treatment of cellular proliferation |
| 11/07/2001 | EP1150669A1 L-arginine based formulations for treating diseases and methods of using same |
| 11/07/2001 | EP1150667A1 Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 11/07/2001 | EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 11/07/2001 | EP1150665A2 Use of statins for treating viral infections |
| 11/07/2001 | EP1150664A2 Novel use of orexin receptor antagonists |
| 11/07/2001 | EP1150662A1 Laminates containing an active substance for transdermal systems |
| 11/07/2001 | EP1150661A2 Topical sprays comprising a film forming composition |
| 11/07/2001 | EP1150660A1 Pharmaceutical effervescent formulation containing metamizol |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/07/2001 | EP1150657A1 SPRAY CONTAINING UBIQUINONE Qn |
| 11/07/2001 | EP1150655A1 Use of nanoscale chitosanes and/or chitosane derivatives |
| 11/07/2001 | EP1150652A1 Skin lightening agents |
| 11/07/2001 | EP1150648A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 11/07/2001 | EP1150647A1 Mono and dialkyl quats with silicone in conditioning compositions |
| 11/07/2001 | EP1150630A1 Prolonged release bioadhesive vaginal gel dosage form |
| 11/07/2001 | EP1150629A1 Drug dosage unit for buccal administration of steroidal active agents |
| 11/07/2001 | EP1150621A1 Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers |
| 11/07/2001 | EP1150579A1 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 11/07/2001 | EP1150564A1 Inositol derivatives for inhibiting superoxide anion production |
| 11/07/2001 | EP1089620A4 Hydrophilic polymer blends used to prevent cow skin infections |
| 11/07/2001 | EP1014956A4 Methods of using integrin modulators |
| 11/07/2001 | EP1011648B1 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 11/07/2001 | EP1003532B1 Lactobacilli to increase absorption of minerals by intestinal cells |
| 11/07/2001 | EP0981351B1 Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder |
| 11/07/2001 | EP0980205A4 Method of treating malignancies |
| 11/07/2001 | EP0970043B1 Compounds consisting in particular of effectors of the central nervous system receptors sensitive to excitatory amino acids, preparation and biological applications |
| 11/07/2001 | EP0925273B1 Pharmaceutical composition containing 4-oxo-butynic acids |
| 11/07/2001 | EP0918469B1 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 11/07/2001 | EP0912535B1 Conjugates of cis-docosahexaenoic acid and paclitaxel |
| 11/07/2001 | EP0900082B1 Use of pyridyl- and pyrimidyl-piperazines for the manufacture of a medicament for the treatment of substance abuse disorders |
| 11/07/2001 | EP0896819A4 Antiglucocorticoid drug |
| 11/07/2001 | EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 11/07/2001 | EP0871626B1 triazolones as apolipoprotein-b synthesis inhibitors |
| 11/07/2001 | EP0861235B1 Substituted benzylaminopiperidine compounds |
| 11/07/2001 | EP0848705B1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 11/07/2001 | EP0845007B1 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 11/07/2001 | EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 11/07/2001 | EP0843676B1 Preparations containing ipratropium bromide enantiomer with a prolonged duration of action |
| 11/07/2001 | EP0836475B1 Controlled release formulations for poorly soluble drugs |
| 11/07/2001 | EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment |
| 11/07/2001 | EP0825865B1 Transdermal therapeutic system for administering testosterone |
| 11/07/2001 | EP0804161B1 Continuous method of grinding pharmaceutical substances |
| 11/07/2001 | EP0802917B1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 11/07/2001 | EP0799048B1 Body fluid replacement solution |
| 11/07/2001 | EP0799039B1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections |
| 11/07/2001 | EP0777478B1 Inhibitors of rotamase enzyme activity |
| 11/07/2001 | EP0769917B1 Nervonic acid compositions |
| 11/07/2001 | EP0755265B1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 11/07/2001 | EP0751789B1 Gel for treatment of skin diseases and for disinfection of the skin |
| 11/07/2001 | EP0731705B1 Use of dimeticone for treating constipation |
| 11/07/2001 | EP0726772B1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 11/07/2001 | EP0714296B1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity |
| 11/07/2001 | EP0707479B1 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin |
| 11/07/2001 | EP0670723B1 Use of thioureleylenes and thiabendazole in autoimmune and inflammatory diseases of the skin |
| 11/07/2001 | EP0666079B1 Remedy for parkinson's disease |
| 11/07/2001 | EP0659072B1 Pharmaceutical emulsions containing bioactive steroids |
| 11/07/2001 | EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 11/07/2001 | EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 11/07/2001 | EP0600028B1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
| 11/07/2001 | CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 11/07/2001 | CN1321159A Benzothieno [3,2-c]pyridines as alpha 2-antagonists |
| 11/07/2001 | CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals |
| 11/07/2001 | CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2 |
| 11/07/2001 | CN1321155A Process for preparation of non-crystalline anhydrate form of paroxetine hydrochloride |
| 11/07/2001 | CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof |
| 11/07/2001 | CN1321153A Telomerase inhibitors and method of their use |
| 11/07/2001 | CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators |
| 11/07/2001 | CN1321151A Chemical compounds |
| 11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
| 11/07/2001 | CN1321149A New crystal modification III of torasemide |
| 11/07/2001 | CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use |
| 11/07/2001 | CN1321147A Indolin derivs. as sun protection agents |
| 11/07/2001 | CN1321090A Treatment of vascular restenosis |
| 11/07/2001 | CN1321089A Methods and compositions for increasing intestinal absorption of fats |
| 11/07/2001 | CN1321088A sustained release ranolazine formulations |
| 11/07/2001 | CN1321087A MGluR 5 antagonists for treatment of pain and anxiety |
| 11/07/2001 | CN1321086A Mucosal originated drug delivery system and animal applications |
| 11/07/2001 | CN1321084A Pharmaceutical compositions comprising ibuprofen and domperidone |
| 11/07/2001 | CN1321083A Method for making coated gabapentine or pregabaline particles |
| 11/07/2001 | CN1321082A Micronised pharmaceutical compositions |
| 11/07/2001 | CN1321080A Fast dissolving orally consumable films |
| 11/07/2001 | CN1320606A Method for preparing erythromycin derivs. |
| 11/07/2001 | CN1320605A Anticancer precursor compound containing anthracycle cytotoxins, its preparing process and its medicine |
| 11/07/2001 | CN1320601A 6-amino or 6-hydrazino-sulfonyl-3-quinolyl phosphonic acid compound, preparing process thereof and pharmaceutical composition contg. same |
| 11/07/2001 | CN1320599A Limited 9-cis-isotretinoins |
| 11/07/2001 | CN1320597A Antifungal and its preparation method and intermediate |
| 11/07/2001 | CN1320451A Exterior-applied medicine for treating gynopathy |
| 11/07/2001 | CN1320441A Medicine containing active components of Panax japonicum root and preparing process thereof |
| 11/07/2001 | CN1320440A Medicine containing active components of Rhodiola crennulata root and preparing process thereof |
| 11/07/2001 | CN1320439A Refreshing eyelid liniment for improving vision |
| 11/07/2001 | CN1320433A Process for preparing powdered medicine to treat rhinitis and nasosinusitis |
| 11/07/2001 | CN1320428A Instant effervescent particles for Ca-supplementing health-care products and its preparing process |
| 11/07/2001 | CN1320427A Composite melatonin and its preparing process |
| 11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |